AnterogenCoLtd Valuation

065660 Stock  KRW 15,230  540.00  3.42%   
At this time, the firm appears to be overvalued. AnterogenCoLtd shows a prevailing Real Value of W12765.4 per share. The current price of the firm is W15230.0. Our model approximates the value of AnterogenCoLtd from analyzing the firm fundamentals such as Return On Equity of -5.92, current valuation of 836.51 B, and Profit Margin of (1.32) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
15,230
Please note that AnterogenCoLtd's price fluctuation is very steady at this time. Calculation of the real value of AnterogenCoLtd is based on 3 months time horizon. Increasing AnterogenCoLtd's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AnterogenCoLtd is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AnterogenCoLtd Stock. However, AnterogenCoLtd's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  15230.0 Real  12765.4 Hype  15770.0 Naive  16524.47
The real value of AnterogenCoLtd Stock, also known as its intrinsic value, is the underlying worth of AnterogenCoLtd Company, which is reflected in its stock price. It is based on AnterogenCoLtd's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AnterogenCoLtd's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
12,763
Downside
12,765
Real Value
17,347
Upside
Estimating the potential upside or downside of AnterogenCoLtd helps investors to forecast how AnterogenCoLtd stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AnterogenCoLtd more accurately as focusing exclusively on AnterogenCoLtd's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
14,08515,12816,171
Details
Hype
Prediction
LowEstimatedHigh
15,76815,77015,772
Details
Naive
Forecast
LowNext ValueHigh
16,52216,52416,527
Details

AnterogenCoLtd Total Value Analysis

AnterogenCoLtd is presently forecasted to have takeover price of 836.51 B with market capitalization of 108.41 B, debt of 0, and cash on hands of 6.97 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AnterogenCoLtd fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
836.51 B
108.41 B
0
6.97 B

AnterogenCoLtd Investor Information

About 21.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from AnterogenCoLtd's historical financial statements, AnterogenCoLtd is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.

AnterogenCoLtd Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AnterogenCoLtd has an asset utilization ratio of 5.94 percent. This suggests that the Company is making W0.0594 for each dollar of assets. An increasing asset utilization means that AnterogenCoLtd is more efficient with each dollar of assets it utilizes for everyday operations.

AnterogenCoLtd Ownership Allocation

The market capitalization of AnterogenCoLtd is W108.41 Billion. AnterogenCoLtd retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.

AnterogenCoLtd Profitability Analysis

The company reported the revenue of 8.12 B. Net Loss for the year was (553.98 M) with profit before overhead, payroll, taxes, and interest of 1.72 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AnterogenCoLtd's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AnterogenCoLtd and how it compares across the competition.

About AnterogenCoLtd Valuation

The stock valuation mechanism determines AnterogenCoLtd's current worth on a weekly basis. Our valuation model uses a comparative analysis of AnterogenCoLtd. We calculate exposure to AnterogenCoLtd's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AnterogenCoLtd's related companies.
,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. ANTEROGEN is traded on Korean Securities Dealers Automated Quotations in South Korea.

8 Steps to conduct AnterogenCoLtd's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AnterogenCoLtd's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AnterogenCoLtd's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain AnterogenCoLtd's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine AnterogenCoLtd's revenue streams: Identify AnterogenCoLtd's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research AnterogenCoLtd's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish AnterogenCoLtd's growth potential: Evaluate AnterogenCoLtd's management, business model, and growth potential.
  • Determine AnterogenCoLtd's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AnterogenCoLtd's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for AnterogenCoLtd Stock analysis

When running AnterogenCoLtd's price analysis, check to measure AnterogenCoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnterogenCoLtd is operating at the current time. Most of AnterogenCoLtd's value examination focuses on studying past and present price action to predict the probability of AnterogenCoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnterogenCoLtd's price. Additionally, you may evaluate how the addition of AnterogenCoLtd to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon